Author: IQ TIMES MEDIA
Feb 12 (Reuters) – Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision by the U.S. Food and Drug Administration in April. Last year, the company had said it had nearly $550 million in pre-launch inventory for the pill, orforglipron. Lilly has previously said it would have plenty of supply to launch the much-anticipated weight-loss pill in several countries nearly simultaneously if the pill wins U.S. approval. Danish rival Novo Nordisk launched its once-daily weight-loss pill in the U.S. earlier this month, with prescriptions…
PARIS, Feb 13 (Reuters) – French chemical company Eurolysine has filed a complaint with the European Union saying that a reduction in prices of Chinese lysine, used in animal feed, has made penalties to stop unfair pricing ineffective, it said on Friday. The move highlights wider concerns over cheap Chinese imports affecting several sectors and stoking trade spats between the world’s second-largest economy and the 27-member bloc. Eurolysine, the EU’s sole fermentation-based amino acid producer, said market conditions for lysine, valine and tryptophan had worsened for more than six months, arguing that Chinese prices have fallen below production costs. Lysine,…
By Diana Novak Jones Feb 13 (Reuters) – A jury in Pennsylvania state court on Friday awarded $250,000 to the family of a woman who sued Johnson & Johnson (JNJ) alleging its talc-based baby powder was to blame for her ovarian cancer, according to an attorney for plaintiffs in nationwide talc litigation against the company. The jury in the Philadelphia Court of Common Pleas sided with family members of Gayle Emerson, who claimed that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers, according to attorney Chris Tisi. Jurors awarded Emerson’s family $50,000…
Feb 17 (Reuters) – Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand for its heart devices and diabetes monitors. Medtech firms are benefiting from surging demand for medical procedures as health insurers report higher medical loss ratios — an indication that patients are availing more procedures. Market optimism is also boosted by wider physician uptake and technological advances. The company maintained its fiscal 2026 adjusted per share profit forecast at $5.62 to $5.66. Medtronic’s growth drivers include its pulsed field ablation systems and its transcatheter aortic valve replacement devices, two minimally invasive technologies seeing…
Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin lymphoma. If the settlement wins court approval, Monsanto would make annual payments for up to 21 years. People diagnosed with non-Hodgkins lymphoma who were exposed to Roundup before the proposed legal remedy was announced on Tuesday can file a claim to receive payments, according to Reuters. Non-Hodgkins lymphoma is a type of cancer that develops in white blood cells called lymphocytes, which are part of the body’s infection-fighting immune system. Bayer said…
Feb 17 (Reuters) – Tylenol-maker Kenvue on Tuesday beat Wall Street estimates for fourth-quarter results and announced a global workforce reduction, as it proceeds toward a planned takeover by Kimberly-Clark. Kenvue said its board has approved a plan to optimize its operating model, resulting in a net reduction of its global workforce by about 3.5%. The company had about 22,000 employees as of last year. Kleenex-maker Kimberly-Clark in early November proposed buying Kenvue for more than $40 billion to create a global consumer health company with brands like Band-Aid and Huggies diapers. The merger is expected to close in the…
Feb 18 (Reuters) – Australia’s CSL said on Wednesday it had entered into an exclusive licensing agreement with Eli Lilly and Co, granting it certain rights to develop and commercialise clazakizumab, an antibody aimed at preventing heart-related illness and death in people with end‑stage kidney disease. CSL will receive an upfront payment of $100 million and be eligible to receive potential clinical, regulatory and commercial milestone payments, as well as royalties on global net sales. Clazakizumab blocks IL‑6 from binding its receptor, which may dampen the downstream inflammatory cascade that drives symptoms and disease progression in immuno‑inflammatory disorders, CSL said.…
Feb 18 (Reuters) – Moderna (MRNA) said on Wednesday the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application, after the company made modifications. The reversal, which comes just a week after the FDA’s surprise decision to not review the company’s experimental flu vaccine application, lifted shares of the vaccine maker more than 3% before the bell. The FDA has accepted Moderna’s revised approach seeking full approval for the shot for adults aged between 50 and 64, and accelerated approval for those aged 65 and above, the company said,…
Subsidies. Love ’em or hate them, they dominated the news during the Affordable Care Act’s sign-up season, and their reduction is now hitting many enrollees in the pocketbook. While lawmakers continue to disagree on a way forward, and the politics of affordability keeps the issue front and center, it would be understandable to think these are the only taxpayer-funded health insurance subsidies in the U.S. system. But that would be wrong. “The vast majority of people with health insurance get some kind of federal subsidy for it, from Medicaid to Medicare to the ACA to employer-sponsored insurance,” said Larry Levitt,…
NEW YORK (AP) — Debra Whitman was traveling for work when her father was suddenly admitted to the hospital in serious pain. She jetted home to Maryland and took several days off to care for him in his rural community in eastern Washington state and to set him up with a motorized lift chair that would help him stand up. Fortunately for Whitman, who serves as chief public policy officer at AARP, her employer offers paid time off for caregiving for elderly family members, a benefit which experts say is growing in popularity as the U.S. population ages. “Instead of…